Hawkinson, Tara R. https://orcid.org/0000-0002-8743-5503
Liu, Zizhen
Ribas, Roberto A. https://orcid.org/0009-0008-9024-1292
Medina, Terrymar
Nielsen, Rikke S.
Clarke, Harrison A.
Ma, Xin https://orcid.org/0009-0009-3347-4257
Mueller, Angela C.
Plasencia, Adrielle F.
Sheer, Alexander L.
Simpson, Samantha T.
Soto, Charles M.
Sudderth, Jessica
Cai, Feng https://orcid.org/0000-0001-5192-9520
Cantrell, Alex R. https://orcid.org/0000-0003-4134-9981
Colpaert, Matthieu G.
Shedlock, Cameron J.
Wu, Lei https://orcid.org/0000-0002-1474-8082
Young, Lyndsay E. A.
Kooser, Damon D.
Chen, Li https://orcid.org/0000-0001-9372-5606
Ryan, Alison M. https://orcid.org/0009-0009-7307-053X
Quinones, Sadi
Son, Jihye
Azadi, Parastoo
Deberardinis, Ralph J. https://orcid.org/0000-0002-2705-7432
Prokop, Stefan
Allison, Derek https://orcid.org/0000-0002-5119-2474
Yang, Shuang
Chen, Hongyu
Huang, Yu https://orcid.org/0000-0001-7373-4716
He, Xing
Alonge, Kimberly M. https://orcid.org/0000-0002-2171-1640
Guo, Jingchuan
Guo, Yi
Bian, Jiang
Vander Kooi, Craig W.
Gentry, Matthew S. https://orcid.org/0000-0001-5253-9049
Sun, Ramon C. https://orcid.org/0000-0002-3009-1850
Article History
Received: 26 May 2025
Accepted: 22 April 2026
First Online: 9 June 2026
Competing interests
: M.S.G. has research support and research compounds from Maze Therapeutics, Valerion Therapeutics and Ionis Pharmaceuticals. M.S.G. also received consultancy fee from Maze Therapeutics, PTC Therapeutics and the Glut1-Deficiency Syndrome Foundation. D.A. receives book royalty from Wolters Kluwer. The other authors declare no competing interests.